Obesity remains one of the most pressing public health challenges in the United States and worldwide. Despite the availability of FDA-approved weight loss drugs like GLP-1 receptor agonists (e.g., Ozempic), new research from 2025 is shedding light on a surprising potential ally in obesity management: ivermectin. Initially known as an antiparasitic drug, ivermectin has captured attention in...

IMARC Group, a leading market research company, has recently released a report titled "Molluscicide Market by Source (Chemical Molluscicides, Biological Molluscicides), Form (Pellets, Liquids and Gels, and Others), Application (Agricultural, Non-Agricultural), and Region 2025-2033." The study provides a detailed analysis of the industry, including the global molluscicide market size, share,...

The rising incidence of obesity-related cancers in the United States underscores a pressing public health challenge. While some narratives have attempted to position medications like Ivermectin as alternative health solutions, evidence consistently shows that lifestyle interventions—including diet, exercise, and preventive screening—are the most effective long-term strategies....